Biofilm control strategies in the light of biofilm-forming microorganisms

被引:18
|
作者
Kilic, Tugba [1 ]
Bali, Elif Burcu [1 ]
机构
[1] Gazi Univ, Vocat Sch Hlth Serv, Dept Med Serv & Tech, Program Med Lab Tech, TR-06830 Ankara, Turkiye
来源
关键词
Antibiofilm strategies; Antimicrobial peptides; Antiquorum sensing agents; Biofilm control; Essential oils; Nanotechnology; QUORUM-SENSING INHIBITORS; ESSENTIAL OILS; STAPHYLOCOCCUS-AUREUS; PSEUDOMONAS-AERUGINOSA; SILVER NANOPARTICLES; LISTERIA-MONOCYTOGENES; BACTERIAL-RESISTANCE; ALTERNATIVE STRATEGY; VIRULENCE FACTORS; CURRENT KNOWLEDGE;
D O I
10.1007/s11274-023-03584-6
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Biofilm is a complex consortium of microorganisms attached to biotic or abiotic surfaces and live in self-produced or acquired extracellular polymeric substances (EPSs). EPSs are mainly formed by lipids, polysaccharides, proteins, and extracellular DNAs. The adherence to the surface of microbial communities is seen in food, medical, dental, industrial, and environmental fields. Biofilm development in food processing areas challenges food hygiene, and human health. In addition, bacterial attachment and biofilm formation on medical implants inside human tissue can cause multiple critical chronic infections. More than 30 years of international research on the mechanisms of biofilm formation have been underway to address concerns about bacterial biofilm infections. Antibiofilm strategies contain cold atmospheric plasma, nanotechnological, phage-based, antimicrobial peptides, and quorum sensing inhibition. In the last years, the studies on environmentally-friendly techniques such as essential oils and bacteriophages have been intensified to reduce microbial growth. However, the mechanisms of the biofilm matrix formation are still unclear. This review aims to discuss the latest antibiofilm therapeutic strategies against biofilm-forming bacteria.
引用
收藏
页数:22
相关论文
共 50 条
  • [31] Activity of Organoboron Compounds against Biofilm-Forming Pathogens
    Konaklieva, Monika I.
    Plotkin, Balbina J.
    ANTIBIOTICS-BASEL, 2024, 13 (10):
  • [32] BIOFILM-FORMING CAPABILITIES OF URINARY ESCHERICHIA COLI ISOLATES
    Marhova, M.
    Kostadinova, S.
    Stoitsova, S.
    BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT, 2010, 24 (02) : 589 - 593
  • [33] Alternative strategies for the application of aminoglycoside antibiotics against the biofilm-forming human pathogenic bacteria
    Fazlurrahman Khan
    Dung Thuy Nguyen Pham
    Young-Mog Kim
    Applied Microbiology and Biotechnology, 2020, 104 : 1955 - 1976
  • [34] Alternative strategies for the application of aminoglycoside antibiotics against the biofilm-forming human pathogenic bacteria
    Khan, Fazlurrahman
    Dung Thuy Nguyen Pham
    Kim, Young-Mog
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2020, 104 (05) : 1955 - 1976
  • [35] Role and significance of biofilm-forming microbes in phytoremediation -A review
    Sharma, Pooja
    ENVIRONMENTAL TECHNOLOGY & INNOVATION, 2022, 25
  • [36] Biofilm-forming factors in actinobacillus actinomycetemcomitans involved in colonization
    Saito, T
    Nakashima, K
    Sakurai, K
    Ishihara, K
    Okuda, K
    JOURNAL OF DENTAL RESEARCH, 2003, 82 : 432 - 432
  • [37] Characterization of biofilm-forming cyanobacteria for biomass and lipid production
    Bruno, L.
    Di Pippo, F.
    Antonaroli, S.
    Gismondi, A.
    Valentini, C.
    Albertano, P.
    JOURNAL OF APPLIED MICROBIOLOGY, 2012, 113 (05) : 1052 - 1064
  • [38] Antibiotic susceptibility and biofilm-forming ability of Veillonella strains
    Li, Junli
    Wang, Hejing
    Li, Na
    Zhang, Yikui
    Lue, Xin
    Liu, Bianfang
    ANAEROBE, 2022, 78
  • [39] Antibiotic synergy against biofilm-forming Pseudomonas aeruginosa
    Cernohorska, L.
    Votava, M.
    FOLIA MICROBIOLOGICA, 2008, 53 (01) : 57 - 60
  • [40] Molecular identification and biofilm-forming ability of Elizabethkingia species
    Puah, Suat Moi
    Fong, Sam Pei
    Kee, Boon Pin
    Puthucheary, S. D.
    Chua, Kek Heng
    MICROBIAL PATHOGENESIS, 2022, 162